Motevalli, M. H., Taheri, S., Peiravian, F. and Yousefi, N. (2019) “Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review”, International Pharmacy Acta, 2(1), pp. 2e10:1–6. doi: 10.22037/ipa.v2i1.24856.